Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma

Local Institution - 40222, Koto-ku

Local Institution - 41722, Sayama

Local Institution - 41822, Sapporo

Local Institution - 41922, Okayama

Local Institution - 41422, Hidaka

Local Institution - 40722, Chuo-ku

Local Institution - 40922, Fukuoka

Local Institution - 40122, Isehara City, Kanagawa

Local Institution - 41522, Kashiwa

Local Institution - 41622, Nagoya

Local Institution - 41222, Sendai

Local Institution - 41322, Tsukuba